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Introduction {#sec1}
============

The mosquito *Aedes aegypti* transmits a wide range of pathogens to humans, many with severe consequences on public health, including dengue, Zika, and chikungunya viruses ([@bib18]). For instance, dengue virus (DENV) infects 390 million people annually ([@bib3]) and 50% of the world\'s population is at risk for infection ([@bib5]). DENV belongs to the *Flaviviridae* family and has a positive-sense, single-stranded RNA genome. DENV exists as four genetic types (DENV-1, -2, -3 and 4) that are phylogenetically related and loosely antigenically distinct ([@bib22]). In the wild, mosquitoes acquire DENV by feeding on a viremic host. After the infectious blood meal, DENV infection is first established in the mosquito midgut before spreading systematically and reaching the salivary glands, where the virus engages in further replication ([@bib41]) before being transmitted to the next host via the saliva released during the bite ([@bib43], [@bib4]).

The primary prevention strategy against arboviral diseases relies on the control of vector populations. Current vector control methods are mainly based on insecticides. Despite having been applied for decades, the burden of arboviral diseases keeps increasing ([@bib34]). Human travel, urbanization, climate change, and geographic expansion of mosquito vectors increase pathogen transmission and spread ([@bib54]). Over the last two decades, research efforts have led to the production of laboratory-engineered mosquitoes that either suppress wild vector populations or render them incapable of transmitting pathogens ([@bib8], [@bib56]). As the methods for genetic modification of mosquitoes develop, the need to identify optimal target genes that are naturally involved in mosquito antiviral defenses or required for viral replication also increases. Preferably, such pro- or antiviral target genes would act early during the course of an infection, and, when engineered, would permit early blocking of virus replication, at the level of the midgut cells. This would hinder viral dissemination and make further transmission of the virus impossible.

The majority of our knowledge about insect antiviral immunity originates from investigations in the model organism *Drosophila melanogaster* ([@bib33], [@bib37]), whereas studies in mosquito vectors remain more limited ([@bib2], [@bib49], [@bib27]). The Toll, IMD, and Jak-Stat pathways have been implicated in insect innate immune responses to bacteria, fungi, viruses, and parasites. Their activation triggers translocations of NF-κB-like or Stat transcription factors to the nucleus, inducing the expression of an array of immune genes encoding antimicrobial peptides and virus restriction factors, among others ([@bib2], [@bib49], [@bib27], [@bib33], [@bib37]). Another major branch of insect innate immunity is RNA interference (RNAi), which encompasses several pathways leading to the production of small RNA molecules of different characteristics, such as small interfering RNAs (siRNAs), microRNAs (miRNAs), and P element-induced wimpy testis (PIWI)-interacting RNAs (piRNAs) ([@bib35]). The siRNA pathway is hitherto considered as the cornerstone of antiviral immunity in insects. It is initiated with the sensing and cleavage of viral double-stranded RNA (dsRNA) into 21-nucleotide-long siRNAs by the endonuclease Dicer-2. These siRNAs are loaded in the RNA-induced silencing complex (RISC) that guides Ago2-mediated cleavage of viral target sequences ([@bib35]). Numerous studies reported that depletion of siRNA pathway components in mosquitoes resulted in increased arbovirus replication ([@bib6], [@bib23], [@bib38], [@bib45], [@bib13]).

Although several pathways involved in antiviral immunity have been characterized in mosquitoes, several aspects of anti-DENV defense remain elusive. For example, the siRNA pathway was shown to inefficiently restrict DENV replication in the *Ae. aegypti* midgut ([@bib39]). Besides, most of previous studies have focused on mosquito antiviral or restriction factors that antagonize DENV, but little is known about mosquito host factors with a proviral function, that is, factors enhancing DENV propagation. Several human factors required for DENV infectivity were recently discovered through genome-wide CRISPR screens ([@bib46], [@bib57], [@bib30]), whereas only a handful of DENV host factors have been identified in mosquitoes to date ([@bib29], [@bib21], [@bib47], [@bib42]). Although CRISPR screens cannot be readily carried out in live mosquitoes, transcriptome analysis by high-throughput RNA sequencing is a powerful method to identify DENV host and restriction factors *in vivo* ([@bib48]). For example, novel DENV restrictions factors (DVRF-1 and -2) that depend on the Jak-Stat pathway activation have been uncovered by overlapping transcriptional profiles of mosquitoes infected with DENV and mosquitoes with a hyperactive Jak-Stat pathway ([@bib52]).

In this study, we exploited a unique transcriptomic dataset that we previously generated by performing RNA sequencing on individual midguts in a field-derived *Ae. aegypti* population during early DENV-1 infection ([@bib42]). In addition to a conventional pairwise comparison of gene expression between DENV-infected and uninfected controls, we also used an approach to detect correlations between viral RNA load and gene expression. Of 269 candidate genes identified by either method, only four were differentially expressed upon DENV-1 infection and had expression levels that correlated with viral RNA load in infected mosquitoes ([@bib42]). Among the four candidate genes identified by both methods was a gene encoding a member of the Tudor protein family, Tudor Staphylococcal Nuclease (abbreviated Tudor-SN or TSN), which we selected for further investigation in the present study. Using RNAi-mediated gene knockdown *in vivo*, we found that reduced *TSN* expression resulted in lower viral loads *in vitro* and *in vivo*. Immunofluorescence assays revealed that TSN localized to the nucleolus and did not colocalize to DENV replication sites in DENV-infected cells. Finally, we used a reporter assay and small RNA profiling to show that TSN was not involved in RNAi function in the midgut of adult mosquitoes. Altogether, our results demonstrate that TSN has an early proviral effect on DENV replication in the midgut and could be considered as a target to develop genetically modified mosquitoes that are refractory to DENV infection.

Results {#sec2}
=======

*TSN* Expression Is Upregulated upon DENV-1 Infection and Positively Correlates with Viral Loads {#sec2.1}
------------------------------------------------------------------------------------------------

Our previous transcriptomic analysis revealed that *TSN* (*AAEL000293*) expression was significantly upregulated upon DENV-1 infection relative to mock controls 1 day after exposure to the infectious blood meal ([Figure 1](#fig1){ref-type="fig"}A) but not 4 days post blood meal ([Figure 1](#fig1){ref-type="fig"}B). Inversely, we found that *TSN* expression was not significantly correlated with DENV-1 viral loads 1 day post blood meal ([Figure 1](#fig1){ref-type="fig"}C) but was positively correlated with DENV-1 RNA loads 4 days post blood meal ([Figure 1](#fig1){ref-type="fig"}D). Thus, we concluded that *TSN* expression was induced by DENV-1 infection within 24 h after the infectious blood meal and that subsequently, its expression was positively correlated with DENV-1 replication. The positive correlation was suggestive of a proviral role for *TSN* upon DENV-1 infection.Figure 1*TSN* Is Upregulated upon DENV-1 Infection and Correlates Positively with Midgut Viral Loads(A and B) *TSN* midgut expression levels on day 1 and day 4 post DENV-1 exposure. Log~2~-transformed *TSN* normalized RNA-seq counts are shown in mock-infected (n = 6) and DENV-1-infected (n = 16) midguts. p values of the pairwise t tests are indicated.(C and D) Correlation of *TSN* expression level and viral load in DENV-1-infected midguts on day 1 and day 4 post virus exposure. Log~2~-transformed *TSN* normalized RNA-seq counts are shown as a function of the log~10~-transformed midgut viral load. Black lines represent the linear regression and light purple shaded areas represent the 95% confidence intervals of the regression. Pearson\'s coefficients of determination (r) and p values of the linear regression coefficient are indicated.

TSN Is a DENV Proviral Factor *In Vitro* {#sec2.2}
----------------------------------------

First, we sought to test the proviral role of TSN *in vitro* by using *Ae. aegypti* Aag2 cells in culture. We transfected Aag2 cells with dsRNA to trigger RNAi-mediated knockdown of *TSN* or an exogenous green fluorescent protein (GFP) sequence ([Table 1](#tbl1){ref-type="table"}) and subsequently inoculated them with DENV-1 at a multiplicity of infection of 1. We measured *TSN* expression levels by reverse transcription quantitative PCR (RT-qPCR) at 0, 12, 24, 36, 48, 72 and 96 h post infection and found that *TSN* knockdown efficiency ranged from \~50% to 80% and was statistically significant at most of the time points ([Figure 2](#fig2){ref-type="fig"}A). We visualized TSN protein levels by western blotting using an antibody directed against the human ortholog of TSN named SND1, which also reacted against the *Ae. aegypti* TSN. We confirmed that *TSN* knockdown reduced TSN protein levels by 70%--80% in Aag2 cells at 24 and 48 h post DENV-1 infection, compared with the GFP control ([Figure 2](#fig2){ref-type="fig"}B). To determine whether TSN also augmented viral infection *in vitro*, we measured both DENV-1 RNA levels ([Figure 2](#fig2){ref-type="fig"}C) and DENV-1 infectious titers by focus-forming assay ([Figure 2](#fig2){ref-type="fig"}D) over the course of infection. We found that DENV-1 RNA levels were significantly reduced upon *TSN* knockdown relative to control levels at 24 h post infection ([Figure 2](#fig2){ref-type="fig"}C, p \< 0.01). Moreover, DENV-1 RNA levels were consistently lower in *TSN*-depleted cells from 24 to 96 h post infection. DENV-1 infectious titers were also significantly reduced upon *TSN* knockdown at 24 and 48 h post infection ([Figure 2](#fig2){ref-type="fig"}D, p \< 0.05 and p \< 0.001, respectively). Overall, these data demonstrated a proviral role of TSN *in vitro*.Table 1List of Oligonucleotide Primers and Molecular Probes Used in This StudyOrganismPrimer/Probe[a](#tblfn1){ref-type="table-fn"}Sequence (5′-3′)Product Size (bp)Reference*Ae. aegyptirp49*-FACAAGCTTGCCCCCAACT97([@bib58])*rp49*-RCCGTAACCGATGTTTGGC*TSN*-FCTGCAGATGAACGTCGAGTA100This study*TSN*-RCATCGCTGACCAGTTCCTTdsTSN-F[b](#tblfn2){ref-type="table-fn"}**taatacgactcactataggg**AAAGGCAAATGGAGCGACT312This studydsTSN-R[b](#tblfn2){ref-type="table-fn"}**taatacgactcactataggg**GACGTCACGTTGCAGCAGdsGFP-F[b](#tblfn2){ref-type="table-fn"}**taatacgactcactataggg**ATGGTGAGCAAGGGCGAG501This studydsGFP-R[b](#tblfn2){ref-type="table-fn"}**taatacgactcactataggg**TTACTTGTACAGCTCGTCdsLuc-F[b](#tblfn2){ref-type="table-fn"}**taatacgactcactataggg**CGCCCTGGTTCCTGGAAC556This studydsLuc-R[b](#tblfn2){ref-type="table-fn"}**taatacgactcactataggg**AGAATCTCACGCAGGCAGTTCDENV-1*NS5*-FGGAAGGAGAAGGACTCCACA105([@bib59])*NS5*-RATCCTTGTATCCCATCCGGCT*NS5*-ProbeCTCAGAGACATATCAAAGATTCCAGGGDENV-3*NS5*-FAGAAGGAGAAGGACTGCACA105This study*NS5*-RATTCTTGTGTCCCAACCGGCTCHIKVCHIK_10366_FAAGCTCCGCGTYCTTTACCAAG208(Modified from [@bib60])CHIK_10574_RCCAAATTGTCCYGGTCTTCCT[^4][^5]Figure 2*TSN* Promotes DENV-1 Infection in *Ae. aegypti* Aag2 Cells(A) *TSN* expression levels in Aag2 cells transfected with dsRNA targeting *TSN* (dsTSN) or *GFP* (dsGFP), over the course of DENV-1 infection at a multiplicity of infection of 0.1. Aag2 cells were transfected 3 and 1 day prior to virus infection. *TSN* expression was measured by RT-qPCR and normalized to *rp49*. Data represent mean and standard deviation of three biological replicates. \*p \< 0.05; \*\*p \< 0.01; \*\*\*p \< 0.001 (Student\'s t test). Data are from the same experiment shown in (C) and (D).(B) Western blot analysis of *TSN* expression in Aag2 cells 24 and 48 h after viral infection. An anti-β-actin monoclonal antibody was used for loading control. Molecular mass in expressed in kilodaltons (kDa).(C and D) Analysis of DENV-1 RNA levels (C) or DENV-1 infectious titers (D) over the course of DENV-1 infection following *TSN* or *GFP* knockdown. RNA levels were measured by RT-qPCR on RNA from cell extracts, and infectious titers were determined by focus-forming assay on cell culture supernatants. Data represent mean and standard deviation of three biological replicates. \*p \< 0.05; \*\*p \< 0.01; \*\*\*p \< 0.001 (Student\'s t test).

TSN Is a DENV Proviral Factor *In Vivo* {#sec2.3}
---------------------------------------

To confirm the proviral role of *TSN in vivo*, we experimentally reduced *TSN* expression in adult female mosquitoes by intrathoracic injection of dsRNA and subsequently exposed them to an infectious blood meal containing 10^7^ focus-forming units (FFU)/mL of DENV-1 ([Figure 3](#fig3){ref-type="fig"}A). First, we monitored *TSN* expression levels in individual mosquitoes by RT-qPCR on days 0, 1, and 4 after the infectious blood meal. On day 0, which corresponds to 3 days after injection of dsTSN, *TSN* expression was significantly knocked down relative to mosquitoes injected with a control dsRNA targeting *GFP* ([Figure 3](#fig3){ref-type="fig"}B, p \< 0.001). Reduced *TSN* expression persisted over time through day 1 ([Figure 3](#fig3){ref-type="fig"}C, p \< 0.0001) and day 4 ([Figure 3](#fig3){ref-type="fig"}D, p = 0.01) after exposure to the infectious blood meal. Importantly, reduced *TSN* expression did not significantly impact the survival of mosquitoes during the seven days following injection compared with the dsGFP control ([Figure 3](#fig3){ref-type="fig"}E, p = 0.54). We also measured *TSN* expression in head, thorax, abdomen, ovary, and midgut tissues in sugar-fed or blood-fed mosquitoes and found that *TSN* expression was significantly upregulated in midguts 1 day after a blood meal, suggesting a tissue-specific role within the first day after a blood meal ([Figures S1](#mmc1){ref-type="supplementary-material"}A and S1B, related to [Figure 3](#fig3){ref-type="fig"}). Next, we measured DENV-1 RNA loads by RT-qPCR and found an \~50% reduction of viral loads in mosquito midguts depleted for *TSN*, compared with the GFP control, 4 days after the infectious blood meal ([Figure 3](#fig3){ref-type="fig"}F, p \< 0.0001). We also measured DENV-1 RNA loads one day after the infectious blood meal and did not observe a decrease of viral loads. However, this is most likely due to the presence of viral RNA in the undigested blood still present in the midgut at this time point, as shown in a previous report ([@bib42]). These results confirmed the proviral role of *TSN* during DENV-1 infection in the mosquito midgut 4 days after the infectious blood meal. However, we found no evidence that *TSN* knockdown had an impact on infection prevalence after DENV-1 exposure. Among the mosquito midguts analyzed by RT-PCR on day 4, we found that 88% and 90% were positive for DENV-1 RNA in the *TSN* knockdown and the dsGFP control groups, respectively ([Figure 3](#fig3){ref-type="fig"}G, p = 0.59). In addition to DENV-1, we assessed the proviral role of *TSN* upon infection by another DENV serotype, DENV-3, and the alphavirus chikungunya virus (CHIKV). We injected adult mosquitoes with dsRNA against *TSN* or *luciferase* as a negative control and offered them an infectious blood meal 3 days later. We confirmed *TSN* knockdown ([Figures S2](#mmc1){ref-type="supplementary-material"}A, related to [Figure 3](#fig3){ref-type="fig"}) and observed a significant reduction in DENV-3 RNA levels in individual mosquito midguts ([Figures S2](#mmc1){ref-type="supplementary-material"}B, related to [Figure 3](#fig3){ref-type="fig"}) 4 days post DENV-3 exposure. We confirmed *TSN* knockdown 2 and 4 days post CHIKV exposure ([Figures S2](#mmc1){ref-type="supplementary-material"}C and S2E, related to [Figure 3](#fig3){ref-type="fig"}), but despite a slight reduction of CHIKV RNA levels at both time points the difference with controls was not statistically significant ([Figures S2](#mmc1){ref-type="supplementary-material"}D and S2F, related to [Figure 3](#fig3){ref-type="fig"}). Therefore, we found that TSN acted as a proviral factor for two DENV types, DENV-1 and DENV-3, but not for the alphavirus CHIKV. Overall, our data demonstrated that, although *TSN* does not influence the probability of DENV infection, it promotes early DENV replication in the mosquito midgut.Figure 3*TSN* Promotes DENV-1 Infection in the Mosquito Midgut(A) Experimental scheme of the gene-silencing assays *in vivo.*(B--D) *TSN* expression levels following gene knockdown on day 0 (B), day 1 (C), and day 4 (D) after exposure to DENV-1 infectious blood meal. Mean percentage of gene expression knockdown on day 0 (B), day 1 (C), and day 4 (D) after DENV-1 exposure are indicated. Boxplots show *TSN* expression normalized by *rp49* and expressed as 2^−dCt^ values in n = 12--24 individual mosquito midguts per group. Individuals with less than 50% gene expression knockdown are shown as empty dots. Data are representative of three separate experiments. p values above the graph indicate statistical significance assessed with a Wilcoxon test.(E) Percentage of survival following dsRNA injection and/or DENV-1 exposure. Mosquitoes were injected with dsRNA targeting *TSN* (n = 127), targeting *GFP* (dsGFP, n = 110) 3 days prior to DENV-1 exposure. Non-injected mosquitoes that fed on an infectious (n = 71) or a non-infectious blood meal (n = 62) were used as controls. No significant difference in mortality was detected between dsGFP and dsTSN mosquitoes according to a Cox model (p = 0.54).(F) DENV-1 RNA levels in mosquito midguts dissected from mosquitoes previously injected with dsGFP (n = 53) or dsTSN (n = 55). Boxplots represent the viral load measured by RT-qPCR on day 4 post exposure. Data represent three separate experiments combined. The negative effect of *TSN* knockdown on viral load was statistically significant in each of the three experiments. Viral loads are adjusted for differences between experiments and expressed in mean-centered DENV-1 RNA loads. The p value above the graph indicates statistical significance of the treatment effect assessed with an analysis of variance accounting for the experiment effect.(G) DENV-1 infection prevalence in mosquito midguts measured by RT-qPCR on day 4 post virus exposure following injection with dsGFP (n = 53) and dsTSN (n = 43). Data from three separate experiments were combined after verifying the lack of a detectable experiment effect. Error bars represent 95% confidence intervals of the percentages. The p value above the graph indicates statistical significance of the treatment effect assessed with a logistic regression.See also [Figures S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}.

TSN Localizes to the Nucleolus in Mosquito Cells {#sec2.4}
------------------------------------------------

It was previously shown that TSN could interact with DENV RNA in mammalian cells ([@bib28]), which led us to ask whether TSN co-localized with DENV-derived RNA in mosquito cells. Double-stranded RNA is produced during the replication of single-stranded RNA viruses like DENV and is a hallmark of RNA virus infection ([@bib55]). Previous reports demonstrated that antibodies directed against dsRNA did not cross-react with cellular rRNA or tRNA and could be used to identify flavivirus replication complexes in infected cells ([@bib10]). To determine the subcellular localization of TSN, we performed immunofluorescence assays in mosquito cells derived from *Ae. albopictus* (C6/36, [Figure 4](#fig4){ref-type="fig"}A) or *Ae. aegypti* (Aag2, [Figure 4](#fig4){ref-type="fig"}B) using the anti-SDN1 antibody previously validated by western blotting ([Figure 3](#fig3){ref-type="fig"}B) and a monoclonal antibody targeting dsRNA (called αK1). In both cell types, we found that TSN was expressed and localized to the nucleolus. Indeed, it localized to the nucleus region but did not overlap with DAPI staining, which is reported to exclude the nucleolus ([@bib51]). Moreover, the staining was more intense at the nucleus-nucleolus interface where it formed a "ring." TSN localization did not change upon DENV-1 infection, nor did its expression level. Six days after DENV-1 infection of C6/36 and Aag2 cells, dsRNA staining was readily detectable and mainly localized to cytoplasmic regions of infected cells, likely corresponding to viral replication sites. Since TSN localized to the nucleolus, and the dsRNA to the cytoplasm, we did not observe overlapping signals between both stainings. Thus, we conclude that TSN does not interact with DENV-1 RNA at its replication site. However, it remains possible that interactions occur with other forms of DENV-1 RNA (positive or negative single-stranded RNA) or viral proteins.Figure 4TSN Localizes to the Nucleolus in *Ae. aegypti* and *Ae. albopictus* Cells(A and B) Immunofluorescence assays in *Ae. albopictus* C6/36 (A) or *Ae. aegypti* Aag2 (B) cells 6 days after infection with DENV-1. Cells were stained with the nuclear stain DAPI, an antibody against TSN coupled to an Alexa 488 secondary fluorescent antibody, and an antibody against dsRNA (αK1) coupled to an Alexa 689 secondary fluorescent antibody. Cells were imaged on a confocal microscope at 63× magnification.

RNAi Is Functional in *TSN*-Depleted Mosquitoes {#sec2.5}
-----------------------------------------------

Proteins containing Tudor motifs have been implicated in multiple aspects of RNA metabolism such as RNA splicing or small RNA pathways ([@bib26], [@bib50]). TSN was shown to be a component of the RISC in *Caenorhabditis elegans*, *Drosophila*, and mammals ([@bib7]) and was suggested to participate in RNAi function in the tick *Ixodes scapularis* ([@bib1]). Therefore, we asked whether TSN was involved in RNAi function in *Ae. aegypti*. We adapted a luciferase-based RNAi sensor assay developed in *Drosophila* to mosquitoes ([@bib31], [@bib32], [@bib53]). Adult females were intrathoracically injected with a mix of lipofectant along with Firefly *luciferase* reporter plasmid with Firefly *luciferase*-specific dsRNA and dsRNA targeting *GFP* (as a negative control), *Ago2* (as a positive control), or *TSN* ([Figure 5](#fig5){ref-type="fig"}A). A reporter plasmid encoding a Renilla *luciferase* was used as an *in vivo* transfection control. Three days after injection, the efficiency of Firefly *luciferase* silencing was measured in whole-mosquito homogenates ([Figure 5](#fig5){ref-type="fig"}B). When reporter plasmids were injected together with control dsGFP, we observed a wide range of luminescence counts (likely due to variable *in vivo* transfection efficiency), but the average luciferase activity was about 100-fold higher than when dsRNA targeting Firefly *luciferase* (dsLuc) was co-transfected with the reporter plasmids and control dsGFP. The silencing of Firefly *luciferase* was partially restored upon knockdown of *Ago2*, a key gene of the RNAi pathway, demonstrating the validity of the reporter assay. Finally, we observed that the silencing of Firefly *luciferase* was maintained upon co-transfection with the dsRNA targeting *TSN*, suggesting that *TSN* does not enhance RNAi function in *Ae. aegypti* ([Figure 5](#fig5){ref-type="fig"}B). We measured expression levels of *TSN* and *Ago2* upon co-transfection with reporter plasmids and dsRNA and verified that *TSN* and *Ago2* expression levels were significantly reduced upon knockdown with their specific dsRNA ([Figures 5](#fig5){ref-type="fig"}C and 5D). Although we cannot exclude that residual *TSN* expression could suffice to maintain its activity, the knockdown efficiency was similar to that of *Ago2*. Overall, these results supported the conclusion that *TSN* is not a positive regulator of RNAi in *Ae. aegypti*. One caveat of this RNAi reporter assay is that we could only reliably assess a positive effect of *TSN* on RNAi activity (i.e., measure higher luminescence counts). Indeed, the efficiency of *luciferase* silencing was very high in the presence of dsRNA, which may have prevented our ability to detect a negative effect of *TSN* knockdown on RNAi activity (i.e., lower luminescence counts than the dsLuc + dsGFP control).Figure 5*TSN* Does Not Enhance RNAi Function(A) Experimental scheme. Adult mosquitoes were co-injected with Firefly *luciferase* (Fluc) and Renilla *luciferase* (Rluc) reporter plasmids, and dsRNA targeting Fluc in combination with dsRNA against GFP, TSN or Ago2. Luminescence was measured 3 days post injection.(B) *In vivo* RNAi reporter assay. Reporter gene activity was measured in individual mosquitoes. Luminescence counts of Firefly *luciferase* were normalized to the Renilla *luciferase* counts. Mean and standard deviation are shown. \*p \< 0.05; \*\*p \< 0.01; \*\*\*p \< 0.001 (Mann-Whitney t test).(C and D) Expression levels of *TSN* (C) and *Ago2* (D) measured by RT-qPCR on mosquitoes harvested 3 days after injection with plasmids and dsRNA. Gene expression was normalized by *rp49* and expressed as 2^−dCt^ values.\*p \< 0.05; \*\*p \< 0.01; \*\*\*p \< 0.001 (Student\'s t test). Data are from the same experiment shown in panel (B).

Small RNA Profiling in *TSN*-Depleted Mosquitoes {#sec2.6}
------------------------------------------------

To overcome the limitations inherent to the RNAi reporter assay, and further assess the impact of *TSN* depletion on RNAi activity, we deep sequenced small RNA populations in *TSN*-depleted mosquitoes infected with DENV-1. We first injected adult mosquitoes with dsRNA targeting *TSN* or *luciferase* as a control. Two days later, we exposed mosquitoes to DENV-1 via an infectious blood meal. Four days after exposure to the virus, we performed a second injection of dsRNA against *TSN* and *luciferase* to prolong gene silencing ([Figure 6](#fig6){ref-type="fig"}A). We verified *TSN* knockdown by measuring *TSN* expression levels on days 4 and 10 post infection ([Figures S3](#mmc1){ref-type="supplementary-material"}A, related to [Figure 6](#fig6){ref-type="fig"}). We then selected mosquitoes that were infected with DENV-1 and displayed low *TSN* expression for sequencing, as well as control mosquitoes injected with dsRNA targeting *luciferase* that had equivalent DENV-1 RNA levels but normal *TSN* expression ([Figure S3](#mmc1){ref-type="supplementary-material"}B, related to [Figure 6](#fig6){ref-type="fig"}). These mosquitoes were used to prepare and sequence small RNA libraries and compare the three canonical small RNA populations: miRNAs, siRNAs (21 nucleotides in length), and piRNAs (26--30 nucleotides in length). We first examined small RNAs mapping on the DENV-1 genome. As expected, 21-nucleotide (nt)-long siRNAs where highly abundant in both the *TSN*-depleted mosquitoes ([Figure 6](#fig6){ref-type="fig"}B) and control mosquitoes ([Figure 6](#fig6){ref-type="fig"}C), and they were distributed across the viral genome, on both strands, in both conditions ([Figures S3](#mmc1){ref-type="supplementary-material"}C and S3D, related to [Figure 6](#fig6){ref-type="fig"}). Next, we examined small RNAs mapping on the mosquito genome. We found that *TSN* depletion did not affect the miRNA machinery, as miRNA abundance was very similar between both conditions tested ([Figure 6](#fig6){ref-type="fig"}D). Likewise, we found that *TSN* knockdown did not influence siRNA and piRNA biogenesis. The abundance of both histone-derived siRNAs ([Figure 6](#fig6){ref-type="fig"}E) and histone-derived piRNAs ([Figure 6](#fig6){ref-type="fig"}F) was similar between the *TSN*-depleted mosquitoes and controls.Figure 6Small RNA Populations Are Unchanged Following *TSN* Knockdown(A) Experimental scheme. Adult female mosquitoes were injected with dsRNA targeting *luciferase* or *TSN* 2 days before and 4 days after a DENV-1 infectious blood meal. Whole bodies were harvested on day 10 post infection for RNA extraction and deep sequencing of small RNAs.(B and C) Size distribution of the total number of DENV-1-specific small RNA reads normalized to the total number of reads upon (B) *TSN* knockdown or (C) *luciferase* control.(D--F) Linear relationship between the amount of viral and cellular small RNAs in *TSN* knockdown versus *luciferase* control mosquitoes 10 days post DENV-1 infection. Data points represent the normalized number of reads (coverage per 1M reads) corresponding to (D) miRNAs, (E) endo-siRNAs mapping on histone coding sequences, and (F) endo-piRNAs mapping on histone coding sequences. For miRNAs, each dot represents one miRNA. For siRNAs and piRNAs mapping on histone genes, each dot represents a histone gene. For siRNAs and piRNAs mapping on the DENV-1 sequence, each dot represents a 500-bp region of the viral genome. Lines represent the linear regression of each set of values. The equation and R^2^ value of each regression are shown next to the line.See also [Figure S3](#mmc1){ref-type="supplementary-material"}.

Discussion {#sec3}
==========

Antiviral immunity in *Ae. aegypti* mosquitoes remains poorly understood. Using a novel approach of transcriptomic analysis, we previously uncovered four genes that not only responded to DENV infection in the mosquito midgut but also had expression levels that correlated with viral loads in infected mosquitoes ([@bib42]). Here, we focused on one of these four genes, *Tudor-SN*, encoding a member of the Tudor protein family. *TSN* was induced upon DENV-1 infection, and its expression correlated positively with viral RNA load ([@bib42]). Using RNAi-mediated knockdown assays *in vivo* and *in vitro*, we demonstrated that *TSN* promotes both DENV-1 and DENV-3 replication. *TSN* knockdown also resulted in a slight decrease of CHIKV replication, but it was not statistically significant. We performed localization studies and discovered that TSN localizes to the nucleolus of *Ae. aegypti* and *Ae. albopictus* cells and does not colocalize with DENV-1 replication sites. Moreover, we found that, despite belonging to the Tudor family, TSN was not essential for RNAi function in adult mosquitoes.

TSN is a known component of the RISC, the RNAi protein complex that carries siRNAs and directs cleavage of complementary viral sequences in *Caenorhabditis elegans*, *Drosophila*, and mammals ([@bib7]). Additionally, previous work in *Drosophila* and other model organisms found essential functions for Tudor domain-containing proteins in piRNA biogenesis. A recent study describing a functional knockdown screen of all predicted *Ae. aegypti* Tudor proteins did not reveal a role for Tudor-SN in piRNA biogenesis ([@bib20]). This finding is consistent with our observations that Tudor-SN is not necessary for the piRNA pathway function *in vivo* in *Ae. aegypti*. Finally, Tudor-SN was also shown to be a conserved component of the basic RNAi machinery in *Ixodes* ticks ([@bib1]). This study reported an effect of Tudor-SN on dsRNA-mediated gene silencing, which possibly involves the siRNA pathway. However, no evidence was obtained for a role of Tudor-SN in the response to microbial infection ([@bib1]). Taken together, the data described in this study and discussed above did not find strong links between RNAi function and Tudor-SN in arthropods. Further studies using knockout mutants might be necessary to confirm these findings.

The mammalian ortholog of Tudor-SN is generally referred to as p100 and was identified as a host factor interacting with the 3′ untranslated region of the DENV genome ([@bib28]). Moreover, *p100* knockdown led to reduced levels of viral RNA and protein in mammalian cells, providing evidence that p100 was required for efficient DENV replication. Although these results are consistent with those reported here, in mammalian cells p100 was shown to interact with DENV genomic RNA and dsRNA replication intermediates, which we did not observe. Importantly, the subcellular localization of p100 in mammalian cells was perinuclear, whereas it was nucleolar in mosquito cells. This discrepancy in localization hints to a divergence in function between mammals, in which p100 interacts directly with viral RNA, and insects, for which evidence is lacking. Microscopy-based localization studies being limited in sensitivity and resolution, elucidating Tudor-SN function in mosquitoes will require further experiments to more definitely exclude interactions between viral RNA and Tudor-SN, such as protein immunoprecipitation and sequencing of associated RNA (RIP-seq).

The predicted structure of *Ae. aegypti* Tudor-SN includes four Staphylococcal Nuclease (SN)-like domains and a Tudor domain embedded in a fifth SN domain. Tudor-SN homologs are found in diverse eukaryotic species such as plants, humans (Staphylococcal Nuclease and Tudor domain containing 1), and insects (*Drosophila* Tudor-SN). The very similar structure of eukaryotic Tudor-SN homologs is consistent with potentially conserved functions ([Figure 7](#fig7){ref-type="fig"}). However, Tudor-SN subcellular localization is variable in other species, which also hints toward species-specific function(s) of Tudor-SN proteins.Figure 7Conserved Structure of TSN Homologs Among Diverse Eukaryotic SpeciesStructural domains provided in the UniProt database are shown for homologs of *Ae. aegypti* TSN (Q17PM3) in *Drosophila melanogaster* (Q9W0S7), *Ixodes scapularis* (B7QIP4), *Arabidopsis thaliana* (F4K6N0), and *Homo sapiens* (Q7KZF4). Diagrams on the right side indicate TSN subcellular localization (in green) in the cytoplasm, nucleus, and/or nucleolus of each species based on the literature ([@bib11], [@bib24], [@bib19], [@bib15], [@bib7]).

Our observation that *Ae. aegypti* Tudor-SN localizes primarily to the nucleolus of mosquito cells makes it unlikely that its proviral effect on DENV relies on a direct action on viral genome stability or replication. The nucleolus is a multifunctional nuclear domain involved in ribosome biogenesis and several other cellular functions, such as cell cycle regulation, telomere metabolism, or DNA damage sensing and repair ([@bib25]). Various nucleolar alterations during viral infection have been documented ([@bib44]). Interestingly, DENV non-structural protein 5 (NS5), which encodes the virus RNA-dependent RNA polymerase, was recently shown to localize to the nucleolus of infected mammalian cells ([@bib14]), where it interferes with precursor messenger RNAs (pre-mRNA) splicing to limit host antiviral response ([@bib9]). Human Tudor-SN was implicated in spliceosome assembly and, therefore, may influence splicing of pre-mRNAs and/or interact with DENV NS5 to facilitate viral RNA accumulation ([@bib17]). More generally, Tudor-SN could promote viral replication through regulation of gene expression. For example, the Jak-Stat pathway protects *Ae. aegypti* against DENV infection ([@bib52]) and Tudor-SN was shown to bind Stat proteins to modulate host gene transcription ([@bib40]). Also, Tudor-SN is a component of stress granules ([@bib16]) and could interfere with their formation to facilitate DENV infection ([@bib36]). Particularly interesting is the early proviral effect of *TSN* in the mosquito midgut, which might suggest a role for *TSN* in viral sensing, or early antiviral responses. For instance, *TSN* might sense the infection and, in the nucleus, alter the spliceosome to increase the availability of cellular resources that the virus requires to replicate. Its presence in the nucleolus and at the nucleus-nucleolus interface might enhance ribosome biogenesis and subsequently increase production of viral proteins.

Although several pathways involved in antiviral immunity have been characterized in mosquitoes, several aspects of anti-DENV defense remain to be elucidated, particularly during the early phase of infection. For example, the siRNA pathway was recently shown to inefficiently restrict DENV replication in the *Ae. aegypti* midgut ([@bib39]). The present work adds to the small number of studies that identified DENV proviral factors in mosquitoes ([@bib29], [@bib21], [@bib47], [@bib42]). Such host factors have been proposed as new targets for antiviral therapy in humans ([@bib46], [@bib57], [@bib30]). Although the development of novel vector control methods has focused on viral restriction factors so far ([@bib12]), targeting essential host factors could complement antiviral strategies in mosquitoes. We showed that *Tudor-SN* is such a host factor for DENV in the mosquito *Ae. aegypti*. Further studies will be necessary to elucidate the specific mechanisms underlying the role of Tudor-SN in DENV replication.

Limitations of the Study {#sec3.1}
------------------------

We demonstrated a proviral role of *TSN* upon DENV infection in the mosquito midgut. Our study primarily relied on gene knockdown to diminish *TSN* expression *in vitro* and *in vivo*, and it will be useful in the future to confirm the results using knockout mosquitoes. Second, this study used a strain of *Ae. aegypti* from Thailand, and it remains to be determined whether the proviral role of *TSN* extends to other mosquito strains. Finally, additional in-depth functional studies are required to elucidate the exact role of *TSN*.

Methods {#sec4}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.

Data and Code Availability {#appsec1}
==========================

The accession number for the RNA-seq data set reported in this paper is SRA: PRJNA386455.

Supplemental Information {#appsec3}
========================

Document S1. Transparent Methods and Figures S1--S3
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